Ciba Consumer Pharmaceuticals
Executive Summary
Obtains license to Boehringer Ingelheim's Dulcolax laxative and acquires Boehringer's Nostril and Nostrilla nasal decongestants. Ciba Consumer already markets Fiberall, a bulk laxative, and describes stimulant laxative Dulcolax as "a leader in the laxative market." Ciba currently has two OTC decongestants on the market, Otrivin and Privine. Terms of the deal were not disclosed.